A Phase I Study of Romidepsin, Gemcitabine, Dexamethasone and Cisplatin Combination Therapy in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2018
Price : $35 *
At a glance
- Drugs Romidepsin (Primary) ; Cisplatin; Dexamethasone; Gemcitabine
- Indications Diffuse large B cell lymphoma; Peripheral T-cell lymphoma
- Focus Adverse reactions
- 19 Sep 2018 Status changed from active, no longer recruiting to completed.
- 14 May 2018 Planned End Date changed from 1 Apr 2018 to 1 Dec 2018.
- 14 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Apr 2018.